Related Experiment Video
Updated: Sep 28, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
Published on: January 14, 2014
Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic
Kerstin Kaulich1, Britta Blaschke, Astrid Nümann
1Department of Neuropathology, Heinrich-Heine-University, Düsseldorf, Germany.
Abstract:
Pleomorphic xanthoastrocytoma (PXA) is a rare, usually well-circumscribed and superficially located neoplasm that preferentially arises in the cerebral cortex of children and young adults. The molecular aberrations that are associated with these tumors have not been studied systematically so far. We here report on a molecular genetic analysis of 62 PXAs (46 PXAs of World Health Organization [WHO] grade II and 16 PXAs with anaplastic features) for alterations of 5 candidate genes known to be frequently aberrant in diffusely infiltrating astrocytic gliomas, i.e. TP53, CDKN2A (p16(INK4a)), CDK4, MDM2, and EGFR. Only 3 PXAs (5%) carried a TP53 mutation. None of the 62 PXAs had lost both copies of the CDKN2A gene. The CDK4, MDM2, or EGFR genes were not amplified in any of the tumors. Fourteen PXAs were additionally analyzed for loss of heterozygosity (LOH) at microsatellite markers located on the chromosomes/chromosomal arms 1, gp, 9p, 10, 17, 19q, and 22q. Two PXAs (14%) had LOH at all informative markers on 9p, while 1 PXA demonstrated an interstitial area of allelic imbalance between D22S533 and D22S417 at 22q11.2-q13.3. Further analysis of 10 PXAs for inactivation of the CDKN2A. p14(ARF), and CDKN2B (p15(INK4b)) genes on 9p21 did not reveal any homozygous deletion, mutation, promoter hypermethylation, or complete loss of mRNA expression. Taken together, our results indicate that the chromosomal and genetic aberrations in PXAs are different from those typically associated with the diffusely infiltrating astrocytic and oligodendroglial gliomas. These genetic differences likely contribute to the more favorable behavior of PXAs and may be helpful for the molecular differential diagnosis of cerebral gliomas.
Insights
Molecular analysis of pleomorphic xanthoastrocytoma (PXA) reveals distinct genetic alterations compared to diffuse gliomas. These findings may aid in the differential diagnosis of cerebral gliomas.
Area of Science:
- Neuro-oncology
- Molecular genetics
- Cancer research
Background:
- Pleomorphic xanthoastrocytoma (PXA) is a rare cerebral neoplasm affecting children and young adults.
- Systematic molecular aberration studies in PXA are limited.
- Understanding PXA molecular genetics is crucial for diagnosis and treatment.
Purpose of the Study:
- To investigate molecular genetic alterations in 62 PXAs.
- To compare genetic profiles of PXA with diffusely infiltrating astrocytic gliomas.
- To identify potential molecular markers for PXA diagnosis.
Main Methods:
- Analysis of 62 PXAs for mutations in TP53, CDKN2A, CDK4, MDM2, and EGFR.
- Loss of heterozygosity (LOH) analysis on chromosomes 1, 9p, 10, 17, 19q, and 22q.
- Investigation of gene inactivation on 9p21 in a subset of PXAs.
Main Results:
- TP53 mutations found in only 5% of PXAs.
- No amplification of CDK4, MDM2, or EGFR genes.
- LOH observed on 9p in 14% and on 22q in one PXA.
- No homozygous deletion, mutation, or hypermethylation of CDKN2A, p14ARF, or CDKN2B.
Conclusions:
- PXAs exhibit distinct chromosomal and genetic aberrations compared to diffuse gliomas.
- These genetic differences likely contribute to the more favorable clinical behavior of PXA.
- Molecular findings may assist in the differential diagnosis of cerebral gliomas.
More Related Videos
10:13Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Published on: August 12, 2014
10:58Transposon Mediated Integration of Plasmid DNA into the Subventricular Zone of Neonatal Mice to Generate Novel Models of Glioblastoma
Published on: February 22, 2015
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancers Originate from Somatic Mutations in a Single Cell
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...